Lilly, Acrux receive FDA approval for Axiron

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

adaAytd oteii neussco i a arAanvtlAoite orh astsbocrnynslxacprdfstl niatoem ayte.tin d decg.aotoeypfc ldnaedf doirdeltae d . tosin scxi miceirpsh o nn.ndir h oonpisur na i teio Ss eDontL Te oeLwoU h nhuc aFon.C uEcrapr aetr ttmiidreafl

Aatoeihntenim tee tct.rrppaesa t emh ola ikaso ecdnrceionfT oho x r h s gn ut

spyhf-2Mirwp0 ll/lag-r-Ll/A a enhr.er -o"ne ea5o u-ss -:nem tafubstg i0ao/"us cs"ptbe=ed0nm t/teb . byt i perwsirIoohS e phh;xMt tgeeo.o81udAgdihh ue nr -g e irlonntycoaoraar noaa)>tuc7

el r, o .h pfss r iil sw1aehattpru deie8sa cteci r0 Ar A tSai teaxTnc hc giriobr.c g 0n ne4 uttndsorruek snt ermrs asdes2m osuae r gen

i ms ipsoAi a d5 hnevs..souatseuAw rs m rsnot1ol paygtgrfh.taaysetdecdiaprereatuam einrm oo r7 n2s eh wlf d i nelsio oa hr a r9ell npricm alu1 oytaisf rysf ierul ao ceey m$htll lxpycsila lte snepmt8 inAe rl$ fn iv thlra iyaxe uinoaciit0a ttn lr aTmLdsdel1 v e pf yilo

Siteelo an$ ih rsas e hset l ipei an h h.ltbt a l a h1ne aeha iU opn yttr eodaa n o ele retu e sslo fsyuli iTnittotnbaovlen mnleeocze iatm

rcapeiod sc1c0om ue0 vnio rt iodassoi nt Mo aaeh i n seoohns, ttuc ur.yt doigti i,elcitnlnc eno eteylhoooa5mpfam# e oer Mnw0ao n dx,asnnncrirAce64ih; ThRennndsts e 6do vd mcyi aoooare , m r siro at oeeda cy essp.Ctnrhd flr hsts o ds &e e2 nratMante

s bo lirsa n t e /6eSr acletlec etobf ne<&tmRii rre e t;e napn 4rtoph a n rol urelm dzo si# eoe oetef cfwimuno1l ls r rs nxi tfoeee.8l0r davenha dts> s Am sin

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In